Immunogenicity and safety of a quadrivalent inactivated influenza virus vaccine compared with a comparator quadrivalent inactivated influenza vaccine in a pediatric population: A phase 3, randomized noninferiority study
Vaccine(2017)
摘要
•First report of Seqirus IIV4 in children aged 5–17years.•Immunogenicity of Seqirus IIV4 was noninferior to a US-licensed comparator IIV4.•Fever rates were similar for both vaccines in children 5–8years and 9–17years.
更多查看译文
关键词
AE,CI,FAS,GMFI,GMT,HI,IIV3,IIV4,SAE,SCR,SD,SPR,TDOC,US
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络